|
|
Volumn 33 Suppl 2, Issue , 2012, Pages 253-257
|
|
[Update on Barrett esophagus and Barrett carcinoma].;Update zum Barrett-Ösophagus und Barrett-Karzinom.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
EGFR PROTEIN, HUMAN;
EPIDERMAL GROWTH FACTOR RECEPTOR;
EPIDERMAL GROWTH FACTOR RECEPTOR 2;
ERBB2 PROTEIN, HUMAN;
MONOCLONAL ANTIBODY;
SCATTER FACTOR RECEPTOR;
TRASTUZUMAB;
ADENOCARCINOMA;
ADJUVANT THERAPY;
BARRETT ESOPHAGUS;
CANCER STAGING;
CARCINOMA IN SITU;
CARDIA;
COOPERATION;
DRUG ANTAGONISM;
DRUG DELIVERY SYSTEM;
ESOPHAGUS TUMOR;
GENETICS;
HUMAN;
INTERDISCIPLINARY COMMUNICATION;
LYMPH NODE METASTASIS;
MULTIMODALITY CANCER THERAPY;
PATHOLOGY;
PRECANCER;
REVIEW;
STOMACH FUNDUS;
STOMACH MUCOSA;
TUMOR INVASION;
ADENOCARCINOMA;
ANTIBODIES, MONOCLONAL, HUMANIZED;
ANTINEOPLASTIC AGENTS;
BARRETT ESOPHAGUS;
CARCINOMA IN SITU;
CARDIA;
COMBINED MODALITY THERAPY;
COOPERATIVE BEHAVIOR;
DRUG DELIVERY SYSTEMS;
ESOPHAGEAL NEOPLASMS;
GASTRIC FUNDUS;
GASTRIC MUCOSA;
HUMANS;
INTERDISCIPLINARY COMMUNICATION;
LYMPHATIC METASTASIS;
NEOADJUVANT THERAPY;
NEOPLASM INVASIVENESS;
NEOPLASM STAGING;
PRECANCEROUS CONDITIONS;
PROTO-ONCOGENE PROTEINS C-MET;
RECEPTOR, EPIDERMAL GROWTH FACTOR;
RECEPTOR, ERBB-2;
|
|
EID: 85027940022
PISSN: None
EISSN: 14321963
Source Type: Journal
DOI: 10.1007/s00292-012-1662-0 Document Type: Review |
|
Times cited : (5)
|
|
References (0)
|
